FeesSafety
Pluang+

Brain cancer diagnostics market to nearly double by 2034, driven by tech advances and rising tumor cases.

20 Nov 2026, 01:00 WIB
Delveinsight
View Source
Bullish
Brain cancer diagnostics market to nearly double by 2034, driven by tech advances and rising tumor cases.

The global brain cancer diagnostics market is projected to grow from USD 4.1 billion in 2025 to USD 9.85 billion by 2034, at a CAGR of about 10.2%. Growth is fueled by increasing brain tumor incidence, adoption of advanced imaging and molecular diagnostics, and innovations like AI-assisted imaging and liquid biopsies. North America leads the market, while Asia-Pacific is the fastest-growing region. This expansion supports early diagnosis and personalized treatments, with major companies advancing technology and research.

Brain cancer diagnostics market growth is projected at a CAGR of about 10.2% through 2034. For readers following health-sector stocks, here is Pluang's market snapshot as of Nov 19, 2026 23:12 WIB: out of 150 priced US health stocks, 42 rose and 106 fell. Notable movers include ABEO at USD 2.52 with a 7.69% drop, TXG at USD 60.75 with a 6.45% gain, and HRTX at USD 0.26 with a 6.30% decline.

More News

Google switches satellite launch partner from SpaceX to Blue Origin for AI project.

Google switches satellite launch partner from SpaceX to Blue Origin for AI project.

Google initially launched its first Project Suncatcher AI satellite with SpaceX but has now signed a launch agreement with Blue Origin for a dedicated mission in early 2029. This shift comes amid SpaceX's threat to halt future Falcon 9 commercial lau...

Market News
Bullish
28 minutes ago
Adobe and Synopsys compete as top tech growth picks with distinct strengths and risks for 2027 investors.

Adobe and Synopsys compete as top tech growth picks with distinct strengths and risks for 2027 investors.

Adobe leads in creative software with strong revenue growth and a new AI partnership with Disney, offering stable long-term prospects despite management changes. Synopsys excels in semiconductor design tools, boosted by its Ansys acquisition and expa...

Bullish
29 minutes ago
Sandisk's stock drops two-thirds despite net income quadrupling, making it a potential buy at 6 times earnings.

Sandisk's stock drops two-thirds despite net income quadrupling, making it a potential buy at 6 times earnings.

Sandisk's net income for the trailing 12 months has surged to around $19.4 billion, more than four times its level in June, while its stock price has fallen to about a third of its June peak. This drop means the stock now trades at roughly 6 times ea...

Market News
Bullish
30 minutes ago
Vertex and Regeneron rebound with strong drug pipelines and new product approvals boosting growth.

Vertex and Regeneron rebound with strong drug pipelines and new product approvals boosting growth.

Vertex Pharmaceuticals is poised for growth with potential FDA approval of povetacicept for kidney disease and a strong cystic fibrosis drug franchise, alongside a $10 billion acquisition expanding its pipeline. Regeneron is thriving with Dupixent's ...

Market News
Bullish
43 minutes ago
NBT Bancorp posts record $143M net interest income in Q3 2026, driven by loan growth and fee revenue.

NBT Bancorp posts record $143M net interest income in Q3 2026, driven by loan growth and fee revenue.

NBT Bancorp reported a record $143 million in net interest income for Q3 2026, supported by a $427 million increase in loans over nine months and $34 million in fee-based revenue from services like wealth management and insurance. The bank benefits f...

Company Fundamentals
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App